Lifeboat Foundation

Scientists at New York’s Albert Einstein College of Medicine have conducted experiments and found that stem cell implants in the brains of mice can stop aging and help the treated animals remain fitter for longer.

What part of the brain controls aging?

The experiments have helped researchers identify that a part of the brain called the hypothalamus is intimately involved in the aging process. The investigators hope to launch trials in humans to see whether similar treatments with neural stem cells can prolong the life of treated individuals.

Continue reading “Stem Cell Implants in the Brain Could Delay Aging” »

In an open letter that urges governments to act, the scientists describe how Europe has not kept up with the US and China, where the vast majority of leading AI firms and universities are based. The letter adds that while a few “research hotspots” still exist in Europe, “virtually all of the top people in those places are continuously being pursued for recruitment by US companies.”

Exclusive: In an open letter, the scientists say the proposed Ellis institute is essential to avoid brain drain to big tech firms.

Ian Sample Science editor.

Continue reading “Scientists plan huge European AI hub to compete with US” »

3 days left to get into our Initial Community Offering (ICO) for the evolution of the blockchain which I’ve invested and advising.

Welcome to the Holo ICO whitelist registration! You will need to verify your identity and join the whitelist before you can participate in the ICO. The process requires creating an account, completing a quick identity verification, and then adding your Ethereum address to our whitelist. Once whitelisted, your address will be written into our smart contract, and you will be prepared to participate in the Holo ICO.

NOTE: If you are a resident or citizen of the United States, China, or South Korea, you cannot participate in our ICO due to legal and regulatory uncertainty in those jurisdictions. You will be unable to verify or whitelist if you are a resident or citizen of one of these countries.

To learn more about our ICO, visit https://holo.host/ico

http://radicalsciencenews.org/the-origin-of-life/

Radical Science News is about radical breakthroughs and the newest technology and ideas that will change the world.

Click on photo to start video.

You can take a seat anywhere with this wearable chair.

I’m excited to announce I’m now an advisor at Bitnation. I’ve been following their important work for a few years. Many of them are core libertarians way outside the system.

Very fascinating…

AI systems are now more likely to snoop on agents than their human counterparts.

WASHINGTON — The light-lift Vega rocket is Europe’s vehicle of choice for small satellites, but has mainly launched spacecraft weighing hundreds of kilograms. While that’s smaller than what Arianespace normally launches on an Ariane 5 or Soyuz, it’s not the “small” that people generally think of when they think smallsats.

Last week, Arianespace signed a contract with smallsat rideshare organizer Spaceflight Industries of Seattle to conduct two Vega launches with a new adaptor for cubesats and microsats. The first of those launches is expected no sooner than 2019.

Spaceflight will line up the passengers for the Small Spacecraft Mission System (SSMS), an adapter developed by the European Space Agency to accommodate 10 to 15 smallsats ranging from single-digit-kilogram cubesats to microsats up to 400 kilograms.

Wilmington, DE, April 19, 2018 — Scientists at Christiana Care Health System’s Gene Editing Institute have developed a potentially breakthrough CRISPR gene-editing tool. It could allow researchers to take fragments of DNA extracted from human cells, put them into a test tube, and quickly and precisely engineer multiple changes to the genetic code, according to a new study published today in the CRISPR Journal.

Investigators at the Gene Editing Institute, which is part of the Helen F. Graham Cancer Center & Research Institute at Christiana Care, said their new “cell-free” CRISPR technology is the first CRISPR tool capable of making multiple edits to DNA samples “in vitro,” which means in a test tube or petri dish. The advance could have immediate value as a diagnostic tool, replicating the exact genetic mutations found in the tumors of individual cancer patients. Mutations that cause cancer to spread can differ from patient to patient, and being able to quickly identify the correct mutation affecting an individual patient can allow clinicians to implement a more targeted treatment strategy.

“With this new advance, we should be able to work with laboratory cultures and accomplish gene edits in less than a day, significantly reducing the time required for diagnostics compared to other CRISPR tools, and with much greater precision,” said Eric Kmiec, Ph.D., director of the Gene Editing Institute and principal author of the study. “This is particularly important for diagnostics linked to cancer care where time is critical.”